Next Article in Journal
Prevention of Ageing—The Role of Micro-Needling in Neck and Cleavage Rejuvenation: A Narrative Review
Next Article in Special Issue
How Does Hedonic Aroma Impact Long-Term Anxiety, Depression, and Quality of Life in Women with Breast Cancer? A Cross-Lagged Panel Model Analysis
Previous Article in Journal
Self-Regulated Learning Strategies for Nursing Students: A Pilot Randomized Controlled Trial
Previous Article in Special Issue
Bone Metastases of Endometrial Carcinoma Treated by Surgery: A Report on 13 Patients and a Review of the Medical Literature
 
 
Article
Peer-Review Record

Endometrial Cancer in Pre-Menopausal Women and Younger: Risk Factors and Outcome

Int. J. Environ. Res. Public Health 2022, 19(15), 9059; https://doi.org/10.3390/ijerph19159059
by Nurliza Abdol Manap 1, Beng Kwang Ng 1,*, Su Ee Phon 1, Abdul Kadir Abdul Karim 1, Pei Shan Lim 1 and Maimunah Fadhil 2
Reviewer 1:
Reviewer 2:
Reviewer 3:
Int. J. Environ. Res. Public Health 2022, 19(15), 9059; https://doi.org/10.3390/ijerph19159059
Submission received: 27 April 2022 / Revised: 20 July 2022 / Accepted: 22 July 2022 / Published: 25 July 2022
(This article belongs to the Special Issue Gynecologic Oncology: Diagnosis, Treatment and Prevention)

Round 1

Reviewer 1 Report

No comments

Author Response

Please see the attachment 

Author Response File: Author Response.docx

Reviewer 2 Report

1.      What is the fertility preserve policy of pre-menopause women may need to be mentioned.

2.      How the diagnosis of EM cancer was made in pre-menopause women should  be mentioned.

3.      How many the EM cancer accidently noted after operation should be mentioned. 

4.      The prognosis factor and survival may be analyzed over pre-menopause women group. 

5.       The cohort in this study diagnosed with endometrial cancer between 2002-2020. Which version of FIGO or AJCC staging system did you adopt? 

6.      The survival outcome in pre-menopausal women group is better than post-menopausal group. It is possible due to most of them were endometrioid type, and there were more patients diagnosed as grade 1 disease than post-menopausal group. Besides, in pre-menopausal women, there was a lower recurrence rate after adjuvant therapy in stage 1 disease. However, the mean survival time of “stage 1, low risk” patients is much worse than “stage 1, low-intermediate/high intermediate” patients in both pre-menopausal women and post-menopausal women. Is it possible under-estimated or over-estimated due to the missing data? 

Author Response

Please see the attachment

Author Response File: Author Response.docx

Reviewer 3 Report

In their Systematic research “Endometrial Cancer In Pre-Menopausal Women And Younger: Risk Factors And Outcome" the authors, Manap et al. intended to incorporate scientific data and ascertain the clinical characteristics, risk factors, outcomes, and survival in pre and postmenopausal women with endometrial cancer. This constitutes an interesting and broadly coherent body of work.

However, a few substantial issues need to be resolved, as listed below.

1.     Please include a brief statement in the abstract stating that the research was restricted to the Malaysian population, as otherwise, it appears that the figures are based on a global database.

2.     The introduction by the authors contains a variety of approaches, which muddles the main topic of this research project. I would suggest the authors to rewrite the introduction, please.

3.     Please make a flow chart for the study design.

4.     In the result section, please insert the subgroup.

5.     In the method section, the authors have mentioned that they have done histological analysis. Please provide representative Histological pictures.

 

 

 

 

Author Response

Please see the attachment

Author Response File: Author Response.docx

Back to TopTop